open access
Vol 52, No 6 (2021)
Editorial
Submitted: 2021-11-08
Accepted: 2021-12-06
Get Citation
Therapeutic drug monitoring: a key point in optimal treatment of invasive fungal disease
Jan Styczyński1
DOI: 10.5603/AHP.2021.0098
·
Acta Haematol Pol 2021;52(6):526-527.
Affiliations- Department of Pediatric Hematology and Oncology, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toruń, Jurasz University Hospital 1, Bydgoszcz, Poland
open access
Vol 52, No 6 (2021)
EDITORIAL
Submitted: 2021-11-08
Accepted: 2021-12-06
Abstract
Not available
Abstract
Not available
Get Citation
Keywords
hematology, hematooncology
About this articleTitle
Therapeutic drug monitoring: a key point in optimal treatment of invasive fungal disease
Journal
Issue
Article type
Editorial
Pages
526-527
Page views
2896
Article views/downloads
132
DOI
10.5603/AHP.2021.0098
Bibliographic record
Acta Haematol Pol 2021;52(6):526-527.
Keywords
hematology
hematooncology
Authors
Jan Styczyński
References (10)- Lehrnbecher T, Averbuch D, Castagnola E, et al. 8th European Conference on Infections in Leukaemia, 8th European Conference on Infections in Leukaemia. 8th European Conference on Infections in Leukaemia: 2020 guidelines for the diagnosis, prevention, and treatment of invasive fungal diseases in paediatric patients with cancer or post-haematopoietic cell transplantation. Lancet Oncol. 2021; 22(6): e254–e269.
- Gil L, Kałwak K, Piekarska A, et al. Antifungal management in adults and children with hematological malignancies or undergoing hematopoietic cell transplantation: recommendations of Polish Society of Hematology and Blood Transfusion, Polish Society of Pediatric Oncology and Hematology, and Polish Adult Leukemia Study Group, 2020. Acta Haematol Pol. 2020; 51(2): 60–72.
- Styczyński J, Czyżewski K, Ussowicz M, et al. Antimicrobial prophylaxis in patients after hematopoietic cell transplantation: results of a survey of the Polish Federation of Bone Marrow Transplant Centers. Acta Haematol Pol. 2020; 51(3): 183–186.
- Styczyński J, Czyżewski K, Ussowicz M, et al. Antimicrobial prophylaxis in patients after hematopoietic cell transplantation: results of a survey of the Polish Federation of Bone Marrow Transplant Centers. Acta Haematol Pol. 2020; 51(3): 183–186.
- Styczyński J, Piekarska A, Zaucha-Prażmo A, et al. Antimicrobial prophylaxis in adults and children undergoing hematopoietic cell transplantation: 2021 Polish recommendations. Acta Haematol Pol. 2021; 52(6): XXX–XXX.
- Liszka K, Resztak M, Zalewska P, et al. Therapeutic drug monitoring of posaconazole for effective prophylaxis of invasive fungal infections in pediatric patients. A pilot study. Acta Haematol Pol. 2021; 52(6): XXX–XXX.
- Luong ML, Al-Dabbagh M, Groll AH, et al. Utility of voriconazole therapeutic drug monitoring: a meta-analysis. J Antimicrob Chemother. 2016; 71(7): 1786–1799.
- Styczyński J. Infectious complications in children and adults with hematological malignancies. Acta Haematol Pol. 2019; 50(3): 167–173.
- Styczyński J, Czyżewski K, Frączkiewicz J, et al. Clinical spectrum and outcome of invasive mucormycosis in children and adults: Polish experience of the decade 2010–2019. Acta Haematol Pol. 2020; 51(3): 157–163.
- Giebel S, Basak G, Bieniaszewska M, et al. Current status and progress of Polish hemato-oncology. Acta Haematol Pol. 2021; 52(1): 4–17.